Position in ARWR
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$11,443,514
+$2,260,347 QoQ
Shares Held
140,394
-4.1% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#89
of 499 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Derivatives in ARWR
reported options exposure · as of Jun 30, 2023CallValue
$0
CallShares
0
PutValue
$71
PutShares
2
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. ARWR ranks #8 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,551 | $82,484,707 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
64,650 | $40,311,861 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,045 | $31,621,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,020 | $24,349,704 | |
| 5 | RPRX |
Royalty Pharma plc
|
285,630 | $16,015,274 | |
| 6 | EXEL |
Exelixis, Inc.
|
291,162 | $15,842,124 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
56,313 | $13,783,733 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
140,394 | $11,443,514 |
All Filings in ARWR
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,443,514 | 140,394 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $9,183,167 | 146,462 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $8,845,073 | 133,229 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $4,583,341 | 132,889 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,958,267 | 123,941 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,432,192 | 112,417 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,411,052 | 75,056 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,391,749 | 123,477 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,878,938 | 110,771 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,886,397 | 100,923 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,618,839 | 85,583 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,649,925 | 61,404 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,918,757 | 53,807 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $71 | 2 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $852,220 | 33,552 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,279,505 | 31,546 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $684,135 | 20,700 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $588,957 | 16,727 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $781,278 | 16,988 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,074,126 | 16,201 | Shares | Sole | 2022-02-10 | |
| 2021-12-31 | $331 | 5 | Put | Sole | 2022-02-10 | |
| 2021-09-30 | $2,000 | 500 | Put | Sole | 2021-11-12 | |
| 2021-09-30 | $540,893 | 8,664 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $747,947 | 9,031 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $663,829 | 10,011 | Shares | Sole | 2021-05-10 | |
| 2021-03-31 | $663 | 10 | Put | Sole | 2021-05-10 | |
| 2020-12-31 | $921,373 | 12,008 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $333,973 | 7,756 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $334,981 | 7,756 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $205,935 | 7,158 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||